Articles

Impaired nodal shrinkage and apoptosis define the independent adverse outcome of NOTCH1 mutated patients under ibrutinib therapy in chronic lymphocytic leukaemia

Hematology, Dept of Biomedicine and Prevention, University Tor Vergata, Rome, Italy;
Hematology, Dept of Biomedicine and Prevention, University Tor Vergata, Rome, Italy;
Division of Hematology, Universita' Cattolica del Sacro Cuore, Rome, Italy;
Division of Hematology, Ferrarotto Hospital, Catania, Italy;
Cinical and Experimental Hematology Unit, CRO, IRCCS, Aviano (PN), Italy;
Division of Hematology, Universita' Cattolica del Sacro Cuore, Rome, Italy;
Hematology, Dept of Biomedicine and Prevention, University Tor Vergata, Rome, Italy;
Cinical and Experimental Hematology Unit, CRO, IRCCS, Aviano (PN), Italy;
Hematology, Dept of Biomedicine and Prevention, University Tor Vergata, Rome, Italy;
Cinical and Experimental Hematology Unit, CRO, IRCCS, Aviano (PN), Italy;
Hematology, Dept of Biomedicine and Prevention, University Tor Vergata, Rome, Italy;
Hematology, Dept of Biomedicine and Prevention, University Tor Vergata, Rome, Italy;
Hematology, Dept of Biomedicine and Prevention, University Tor Vergata, Rome, Italy;
Ospedale Ferrarotto
Cinical and Experimental Hematology Unit, CRO, IRCCS, Aviano (PN), Italy;
Cinical and Experimental Hematology Unit, CRO, IRCCS, Aviano (PN), Italy;
Haematologica Early view Jul 30, 2020 https://doi.org/10.3324/haematol.2020.251488